Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Xilin YangJuliana C Chan

Abstract

The risk association between low-density lipoprotein (LDL) cholesterol and cancer remains controversial and largely unexplored for people not receiving statin therapy. We examined the risk association between LDL cholesterol and cancer among patients with type 2 diabetes mellitus who were free of cancer at enrolment and whose statin use was known. We considered a variety of nonlinear relationships in our analysis. During a median follow-up period of 4.90 years, cancer developed in 270 (4.4%) of 6107 patients. Among the 3800 patients who did not receive statin therapy, the risk association between LDL cholesterol and cancer was represented by a V-shaped curve. Compared with patients whose LDL cholesterol was at least 2.80 mmol/L but less than 3.80 mmol/L, the risk of cancer, death from any cause or the composite outcome of cancer or death was greater among those with an LDL cholesterol level of less than 2.80 mmol/L (hazard ratio for cancer 1.74, 95% confidence interval [CI] 1.20-2.52) and those with an LDL cholesterol level of 3.80 mmol/L or greater (hazard ratio for cancer 1.87, 95% CI 1.29-2.71). Using 3.8 mmol/L as a reference point, we found that the hazard ratio for cancer for every millimole per litre absolute change in L...Continue Reading

References

Mar 1, 1985·Diabetes Care·M Laakso, K Pyörälä
Aug 23, 1993·Archives of Internal Medicine·R I Horwitz, S M Horwitz
Jan 15, 1999·Clinical and Experimental Pharmacology & Physiology·J Ludbrook
Apr 1, 2000·Clinical and Experimental Pharmacology & Physiology·J Ludbrook
Oct 31, 2002·Statistics in Medicine·Melania Pintilie
Jan 6, 2005·American Journal of Epidemiology·Carmen RodriguezEugenia E Calle
Jan 13, 2005·JAMA : the Journal of the American Medical Association·Sun Ha JeeJonathan M Samet
May 12, 2005·British Journal of Cancer·R HuxleyM Woodward
Aug 9, 2005·Gastroenterology·Suresh T ChariGloria M Petersen
Nov 9, 2005·Current Opinion in Lipidology·James K Liao
Nov 15, 2005·International Journal of Cancer. Journal International Du Cancer·Marie-Claude RousseauJack Siemiatycki
Jan 19, 2006·Journal of the National Cancer Institute·Adeline SeowMimi C Yu
Feb 16, 2006·Current Cancer Drug Targets·Kelly M Swanson, Raymond J Hohl
Mar 17, 2006·Breast Cancer Research and Treatment·Lorraine L LipscombeJanet E Hux
May 30, 2006·Diabetes Research and Clinical Practice·A PatelT Welborn
Aug 25, 2006·The New England Journal of Medicine·Anis RassiMaurício I Scanavacca
Sep 22, 2006·Journal of the American Society of Nephrology : JASN·Ying-Chun MaHai-Yan Wang
Nov 30, 2006·International Journal of Cancer. Journal International Du Cancer·Danielle R L Browning, Richard M Martin
Nov 10, 2007·Diabetes/metabolism Research and Reviews·Wing Yee SoJuliana C N Chan
Mar 12, 2008·Archives of Internal Medicine·UNKNOWN Hong Kong Diabetes RegistryJuliana C N Chan
Apr 1, 2008·The American Journal of Medicine·Igor KarpLouise Pilote

❮ Previous
Next ❯

Citations

May 4, 2011·Annals of Hematology·Jose Manuel Tirado-VélezGermán Perdomo
Aug 30, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Eric L Ding, Frank B Hu
Apr 29, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Gary T C KoJuliana C Chan
Jan 29, 2014·Diabetes Research and Clinical Practice·R C W MaJ C Chan
Jan 29, 2016·Journal of Diabetes and Its Complications·Weijun GuXilin Yang
Feb 15, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hina UsmanNousheen Zaidi
Oct 5, 2010·Diabetes Research and Clinical Practice·Xilin YangJuliana C N Chan
Nov 26, 2009·Diabetes Research and Clinical Practice·Xilin YangJuliana C N Chan
Jul 28, 2009·Preventive Medicine·Xiaoyan ZhangGang Hu
Nov 10, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Areeb IqbalNousheen Zaidi
May 14, 2016·Medicina·Ričardas RadišauskasRūta Everatt
Feb 10, 2012·Diabetes/metabolism Research and Reviews·Xilin YangJuliana C N Chan
Apr 5, 2013·Annals of the New York Academy of Sciences·Ronald C W Ma, Juliana C N Chan
Mar 29, 2014·Diabetes/metabolism Research and Reviews·Xilin YangJuliana C N Chan
Mar 20, 2010·Diabetes Research and Clinical Practice·Andrea O LukWingyee So
Apr 8, 2014·Biochimie·Rimsha MunirNousheen Zaidi
Sep 5, 2015·Current Diabetes Reports·Alice P S Kong, Juliana C N Chan
Mar 12, 2013·ISRN Oncology·Samy L Habib, Maciej Rojna
Mar 25, 2015·Nature Reviews. Endocrinology·Xilin YangJuliana C N Chan
Apr 17, 2012·Diabetes Research and Clinical Practice·Xilin YangJuliana C N Chan
Oct 16, 2016·International Journal of Clinical Practice·Terry McCormackMark Blagden
May 8, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·H WangX Yang
Sep 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xilin Yang, Juliana C N Chan
Feb 3, 2018·Diabetologia·Ronald C W Ma
Apr 26, 2012·World Journal of Diabetes·Xi-Lin Yang, Juliana Cn Chan
Sep 30, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J L Y MongM M Y Waye
Apr 9, 2009·The American Journal of Gastroenterology·Christine HachemHashem El-Serag
May 4, 2013·Diabetes & Metabolism Journal·Hyun Hee ChungKyu Chang Won
Sep 29, 2017·PloS One·Giovanni ZulianiLuigi Ferrucci
Aug 3, 2019·The Journal of Clinical Endocrinology and Metabolism·Xiaoxu HuoXilin Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.